Semaglutide and cardiovascular risk in type 1 diabetes: A predictive modelling analysis in a double-blind, randomised, placebo-controlled cross-over trial.

Authors

Kugathasan, Luxcia; Tsoukas, Michael A; Nardone, Massimo; Sridhar, Vikas S; Muskiet, Marcel H A; Cherney, David Z I; Haidar, Ahmad; Pasqua, Melissa-Rosina

Keywords